Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial

This trial was designed to compare the efficacy and safety between epirubicin (E) and carboplatin (C) in combination with paclitaxel (P) and trastuzumab (H) in neoadjuvant setting. In 13 Chinese cancer centers, 100 patients with HER2-positive, locally advanced breast cancer were 1:1 randomized to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liang, Chen, Sheng, Yang, Wentao, Xu, Binghe, Huang, Tao, Yang, Hongjian, Zheng, Hong, Wang, Yongsheng, Song, Erwei, Zhang, Jin, Cui, Shude, Pang, Da, Tang, Lili, Lei, Yutao, Geng, Cuizhi, Shao, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621920/
https://www.ncbi.nlm.nih.gov/pubmed/26084292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621920/
https://www.ncbi.nlm.nih.gov/pubmed/26084292

Ejemplares similares